Acta Scientific Dental Sciences (ASDS)(ISSN: 2581-4893)

Review Article Volume 7 Issue 2

The Lassa Fever-A Threat in Covid-19

Haritma Nigam1*, Karan Thakkar2, Hani Yousuf Naik3, Heram Singh3, Saurav Kumar4, Rafiya Raheel5, Rashi Bansal6 and Mahboob Hoda3

11Associate Professor, Department of Oral Medicine and Radiology, Pacific Dental College and Research Centre, Udaipur, India
2Intern, Oral Medicine and Radiology, Department of Pacific Dental College and Research Centre, Udaipur, India
3Assistant Professor, Department of Oral and Maxillofacial Surgery, Pacific Dental College and Research Centre, Udaipur, India
4Department Of Oral and Maxillofacial Surgery, Private Practioner, Ranchi, Jharkhand, India
5Assistant Professor and GP Dentist, Department of Oral Medicine and Radiology, Rakcods, UAE
6Intern, Department of Oral Medicine and Radiology, Pacific Dental College and Research Centre, Udaipur, India

*Corresponding Author: Haritma Nigam, Associate Professor, Department of Oral Medicine and Radiology, Pacific Dental College and Research Centre, Udaipur, India.

Received: January 23, 2023; Published: February 07, 2023


The Lassa fever (Haemorrhagic, zoonotic disease) was founded in the town Lassa, Nigeria in 1969th, which is transmitted by rodents. It is an endemic disease located in West Africa. Nosocomial transmission is most common where there is inadequate supply of proper equipments. 80% people with Lassa virus are asymptomatic with an incubation period of 6-12 days. Having diverse symptoms the diagnosis of Lassa fever becomes difficult however clinical features and confirmed laboratory test makes diagnosis of Lassa fever possible. Antiviral drugs can be the mode of treatment for the same.

Keywords: Haemorrhagic Fever; Lassa Fever; Nosocomial Infection; West Africa; Zoonotic Disease


  1. World health organization World Health Organization. “Lassa fever in Nigeria. Emergencies Preparedness, Response Disease Outbreak News (DONs) (2017).
  2. Kumar and Clark's Clinical Medicine,10th Edition, Elsevier (2020).
  3. Centers for disease control and prevention (2015) Lassa fever (2015).
  4. Nigeria centre for disease control. Lassa fever situation report (2020).
  5. Epidemiological trends of Lassa fever in Nigeria from 2015-2021: A review (2021).
  6. John-Ugwuanya A., et al. “Lassa fever and COVID-19 in Africa: a double crisis on the fragile health system”. Journal of Medical Virology 10 (2021):5707.
  7. Reuben RC., et al. “Co-epidemics: have measure against COVID-19 helped to reduce Lassa fever cases in Nigeria?” New Microbes and New Infections 40(2021):100851.
  8. Abbas Abel Anzaku. “Current Trends of Lassa fever Outbreak in Nigeria; A Call for Global Response”. Journal of AIDS and HIV Research 2 (2018):1.
  9. McCarthy M. “USA moves quickly to push biodefence research”. Lancet 360 (2002):732.
  10. , et al. “Infection pattern, case fatality rate and spread of lassa virus in Nigeria”. BMC Infectious Diseases 21.1 (2021)1-9.
  11. Akhiwu HO., et al. “Lasaa fever outbreak in adolescents in north central nigeria: report of cases”. Journal of Virus Eradication 4 (2018): 225-227.
  12. Nigeria centere for Disease control. An update of Lassa fever outbreak in Nigeria (2021).
  13. Mofolorunsho KC. “Outbreak of Lassa fever in nigeria: measures for prevention and control”. The Pan African Medical Journal 23 (2016): 210.
  14. Inegbenebor U., et al. “Prevention of Lassa fever in Nigeria”. Royal Society of Tropical Medicine and Hygiene 104 (2009): 51-54.
  15. Ilori EA., et al. “Epidemiologic and clinical features of lassa fever outbreak in nigeria, January 1- may 6, 2018”. Emerging Infectious Diseases 25 (2019): 1066-1074.
  16. Okogbenin EO., et al. “One-year retrospective review of psychiatric consultations in Lassa fever, southern Nigeria”. Emerging Infectious Diseases 26 (2020): 3091-3093.
  17. Okokhere P., et al. “Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: an observational cohort study”. Lancet Infectious Diseases 18 ():684-695.
  18. Harrison's Principles of Internal Medicine, 20th Edition, Elsevier 1 (2018).


Citation: Haritma Nigam., et al. “The Lassa Fever-A Threat in Covid-19".Acta Scientific Dental Sciences 7.3 (2023): 21-25.


Copyright: © 2023 Haritma Nigam., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.278

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US